Presilium Private Wealth’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$219K Sell
15,133
-93
-0.6% -$1.25K 0.03% 92
2026
Q1
$211K Buy
15,226
+9
+0.1% +$125 0.04% 73
2025
Q4
$214K Buy
+15,217
New +$213K 0.04% 74

Other funds holding RDY

Presilium Private Wealth's RDY Position: Q2 2026 in Review

Presilium Private Wealth reduced its Dr. Reddy's Laboratories (RDY) stake by 0.61% in Q2 2026, selling an estimated $1.25K and leaving 15,133 shares worth $219K. The position accounts for 0.03% of the portfolio, ranked #92.

Presilium Private Wealth first reported a position in RDY in Q4 2025 and has held it in 3 quarters since. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Presilium Private Wealth held 15,133 shares of Dr. Reddy's Laboratories worth $219K as of Q2 2026.
  • Presilium Private Wealth sold 93 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $1.25K.
  • Dr. Reddy's Laboratories made up 0.03% of Presilium Private Wealth's portfolio in Q2 2026, its #92 holding.
  • Presilium Private Wealth first reported a position in Dr. Reddy's Laboratories in Q4 2025 and has held it in 3 quarters since.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Presilium Private Wealth's 13F filing for Q2 2026, filed 22 Jul 2026.